![]() James J. Chen, Ph.D., MBAPresident, Global Operations |
Dr Chen is a recognized ICH regulatory compliance and submission expert in the pharmaceutical scientific community and a recognized entrepreneur with highest ethical standards and integrity in the business community. Dr Chen has 15+ years of US pharmaceutical research, development and commercialization experience. Dr Chen has authored 15+ peer-reviewed scientific publications and presented 30+ presentations in international meetings in US, Canada, Europe, Japan, Korea and China. In addition, Dr Chen is a faculty member of the Pharmaceutical Training Institute and a member of the Beta Gamma Sigma, a Honorary Business Society. Prior to founding Agno Pharma, Dr Chen has worked for Merck and Schering-Plough (now Merck). Dr Chen holds a Ph.D. in chemistry from University of Pittsburgh, a Meck-sponsored MBA, and a BSc from State University of New York at Stony Brook. |
![]() Raymond Dagnino JrExecutive Director, Business Development |
Mr Dagnino is a recognized expert in the pharmaceutical chemical process research and development community and in pharmaceutical sourcing and supply chain management. In addition, Mr Dagnino is recognized for his highest ethical standards and integrity in the pharmaceutical community and beyond. Mr Dagnino has more than 20+ years of US pharmaceutical research, development and commercialization experience. Prior to joining Agno Pharma, Mr Dagnino has worked for Pfizer, Scripps Research Institute, and Neurocrine Biosciences. Mr Dagnino holds a B.Sc. from San Diego State University. |
![]() Ralph Freese, M.S.Senior Director, Business Development |
Mr Freese is a recognized expert in the chemical process research and development community, particularly with the utilization of catalysts in chemical synthesis. In addition, Mr Freese is recognized for his highest ethical standards and integrity in the business community and beyond. Mr Freese has more than 20+ years of US chemical and pharmaceutical research, development and commercialization experience. Prior to joining Agno Pharma, Mr Freese has worked for Roche, Degussa, and Engelhard. Mr Freese holds a M.S. in chemistry from Rutgers University and a B.Sc. from Lafayette College. |
![]() Bin Li, Ph.D.Vice President, R&D |
Dr Li is a recognized expert in the pharmaceutical chemical process research development community. Dr Li has more than 10+ years of US pharmaceutical discovery and research experience. Dr Li has authored 20+ peer-reviewed scientific publications and presented 10+ presentations in international meetings. Prior to joining Agno Pharma, Dr Li has worked for Neurocrine Biosciences, a San Diego based drug discovery and research company. Dr Li holds a Ph.D. in chemistry from Shanghai Institute of Organic Chemistry under the supervision of a member of the Academy of Science. |
![]() Season ZhuDirector, Quality |
Ms Zhu is a recognized expert in the area of regulatory compliance and quality control. Ms Zhu has experienced in initiating, implementing and managing ICH cGMP quality systems that have been successfully inspected by US-FDA and ICH clients. Ms Zhu has experience in hosting and leading US-FDA inspections. Over the last several years, Ms Zhu has led many successful audits of our strategic partners. Prior to her position in Quality, Ms Zhu has worked and managed analytical methods development and validation. Ms Zhu holds a B.Sc. from Anhui Normal University in Analytical Chemistry. |